Biblio

Author Title [ Type

] Year

Filters: Author is Han, Feng [Clear All Filters]

Journal Article

Tian Y, Chen W, Du G, Gao J, Zhao Y, Wang Z, Su M, Hu R, Han F. Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategies. Biofabrication. 2024.

Ma M, Zou F, Abudureheman B, Han F, Xu G, Xie YJ, Qiao K, Peng J, Guan Y, Meng H, et al. Magnetic Microcarriers with Accurate Localization and Proliferation of Mesenchymal Stem Cell for Cartilage Defects Repairing. ACS Nano. 2023.

Chen Q, Tang L, Liu N, Han F, Guo L, Guo S, Wang J, Liu H, Ye Y, Zhang L, et al. Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study. Cancer Commun (Lond). 2018;38(1):66.

Xin Y, Gao J, Hu R, Li H, Li Q, Han F, He ZX, Lai L, Su M. Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplanation. Immunol Lett. 2020.

Huang Y, Han F, Li J, Li Y, Gao J, Lai L, Luo P, Su M, Hu R. BTN2A2-Ig protein inhibits the differentiation of pathogenic Th17 cells and attenuates EAE in mice. Immunol Lett. 2023.

Qin Z, Han Y, Du Y, Zhang Y, Bian Y, Wang R, Wang H, Guo F, Yuan H, Pan Y, et al. Bioactive materials from berberine-treated human bone marrow mesenchymal stem cells promote alveolar bone regeneration by regulating macrophage polarization. Sci China Life Sci. 2024.